Clinical Trials Logo

Clinical Trial Summary

The objective of this application is to increase PrEP uptake among AA women at-risk for HIV-infection in the rural South, specifically those seeking care at Federally Qualified Healthcare Centers (FQHC) in rural Alabama. The investigators will use a mixed-methods approach to adapt and pilot test a patient-provider communication tool from the CDC PrEP toolkit that focuses on the first three steps of the PrEP cascade (e.g., recognizing HIV risk, identifying as a PrEP candidate, and interested in PrEP) to increase PrEP uptake via referrals to local PrEP clinics.


Clinical Trial Description

The investigators propose: (1) to explore the HIV risk perceptions of AA women with recent PrEP use, AA women who are candidates for PrEP, and providers and identify preferences around patient-provider communication about HIV risk and PrEP services that address the needs of AA women. (2A) To systematically adapt a patient-provider communication tool to increase PrEP uptake at two FQHCs in rural Alabama, using an iterative implementation process; and (2B). To assess the feasibility, acceptability, and preliminary impact of the patient-provider communication intervention on PrEP uptake among AA women and their providers in a pilot pre-/post-intervention design. As part of aim 2B), the investigators will also systematically document and evaluate reasons for declining a PrEP referral, reasons for incomplete referrals, reasons for failing to initiate PrEP after a successful referral, and ongoing PrEP use at 3 months and 12 months post PrEP initiation among our sample. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04373551
Study type Interventional
Source University of Alabama at Birmingham
Contact
Status Enrolling by invitation
Phase N/A
Start date April 14, 2020
Completion date August 30, 2025

See also
  Status Clinical Trial Phase
Completed NCT00787696 - Healthy Teen Girls: HIV Risk Reduction Phase 1/Phase 2
Completed NCT03403569 - Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection Phase 3
Completed NCT02433743 - Impact of RUTF on Body Composition, Anemia and Zinc Status of PLWHA N/A
Recruiting NCT02753049 - Adherence Connection for Counseling, Education, and Support N/A
Completed NCT01360762 - Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study Phase 3
Recruiting NCT03147859 - Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection Phase 2
Recruiting NCT04297488 - Probiotic Supplementation for Those Immune Non-responders With HIV-1 Infection N/A
Completed NCT01827540 - Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam Phase 1
Completed NCT01475890 - Vitamin D Supplementation in HIV Phase 2/Phase 3
Recruiting NCT05947539 - Improving HIV Care Engagement Among Ugandan Adolescent Girls and Young Women: The Kisoboka Mukwano Intervention N/A
Withdrawn NCT01442428 - Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial Phase 2/Phase 3
Completed NCT02496793 - Community-Based Peer Facilitator Intervention (Zimbabwe) N/A
Completed NCT03069235 - Promoting Exclusive Breastfeeding Among HIV Infected Women in a PMTCT Program N/A
Completed NCT03794648 - The Effectiveness of a Mobile Interactive Supervised Therapy (MIST) Intervention for Improving Adherence to HIV Medication N/A
Withdrawn NCT04183738 - Inflammation and Co-Infections in D²EFT Phase 4
Enrolling by invitation NCT03919695 - Development of an Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement Among Fisherfolk in Uganda N/A
Recruiting NCT04215926 - NAFLD in HIV-infected Patients
Completed NCT01406626 - Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care N/A
Completed NCT04371835 - COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings
Completed NCT01140633 - Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in Uganda N/A